Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.94 USD | +1.85% | +8.29% | -5.18% |
May. 10 | HC Wainwright Adjusts Catalyst Pharmaceuticals' Price Target to $26 From $24, Keeps Buy Rating | MT |
May. 09 | Transcript : Catalyst Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 |
End-of-day quotes
Sector Biopharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.88B | - | |||||
89.08B | ||||||
40.9B | ||||||
32.25B | ||||||
25.14B | ||||||
15.39B |